gene in clients relapsing just after therapy With all the BCL2 antagonist venetoclax. 66 Resistance to these agents has become affiliated with these mutations in around 70% of instances, Though they are frequently subclonal and their certain part leading to resistance has to be established.シェア "心拍センサと加速度センサを併用し